Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.polymedicure.com | |
Market Cap | 7,214.50 Cr. | |
Enterprise Value(EV) | 7,320.98 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 14.17 | Trailing Twelve Months Ending 2022-06 |
Price-Earning Ratio (PE) | 53.07 | Trailing Twelve Months Ending 2022-06 |
Industry PE | 56.94 | Trailing Twelve Months Ending 2022-06 |
Book Value / Share | 116.15 | Trailing Twelve Months Ending 2022-06 |
Price to Book Value | 6.47 | Calculated using Price: 751.80 |
Dividend Yield | 0.33 | Period Ending 2021-03 |
No. of Shares Subscribed | 9.59 Cr. | 95,918,392 Shares |
FaceValue | 5 | |
Company Profile | ||
Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products. |
1 Day |
|
+3.13% |
1 Week |
|
+1.57% |
1 Month |
|
-1.75% |
3 Month |
|
-3.94% |
6 Month |
|
+0.78% |
1 Year |
|
-15.80% |
2 Year |
|
+87.06% |
5 Year |
|
+253.21% |
10 Year |
|
+1923.69% |
9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
Return on Equity (%) | 22.63 | 34.10 | 36.03 | 22.35 | 21.81 | 22.76 | 17.80 | 22.98 | 18.94 | |
Return on Capital Employed (%) | 26.73 | 38.77 | 38.90 | 25.59 | 24.37 | 25.39 | 22.19 | 24.43 | 21.58 | |
Return on Assets (%) | 11.75 | 17.59 | 18.97 | 12.64 | 12.92 | 13.58 | 10.27 | 12.66 | 12.83 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03* Rs. Cr. |
Shh. Funds | 112 | 146 | 196 | 229 | 272 | 338 | 381 | 435 | 966 | 1,087 | |
Non Curr. Liab. | 34 | 51 | 55 | 49 | 72 | 104 | 119 | 139 | 87 | 63 | |
Curr. Liab. | 68 | 89 | 113 | 109 | 114 | 123 | 181 | 225 | 215 | 227 | |
Minority Int. | |||||||||||
Equity & Liab. | 214 | 286 | 364 | 387 | 457 | 565 | 682 | 800 | 1,267 | 1,377 | |
Non Curr. Assets | 120 | 166 | 205 | 217 | 252 | 310 | 352 | 450 | 518 | 593 | |
Curr. Assets | 94 | 120 | 160 | 171 | 205 | 255 | 329 | 350 | 749 | 783 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 214 | 286 | 364 | 387 | 457 | 565 | 682 | 800 | 1,267 | 1,377 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-06 Rs. Cr. TTM |
Net Sales | 260 | 322 | 390 | 412 | 455 | 520 | 611 | 687 | 786 | 960 | |
Other Income | 0 | 1 | 8 | 8 | 14 | 14 | 18 | 18 | 18 | 32 | |
Total Income | 260 | 323 | 398 | 421 | 469 | 535 | 629 | 706 | 805 | 992 | |
Total Expenditure | -207 | -247 | -304 | -325 | -362 | -398 | -480 | -521 | -570 | -756 | |
PBIDT | 53 | 77 | 94 | 96 | 107 | 136 | 150 | 185 | 235 | 236 | |
Interest | -7 | -9 | -10 | -10 | -9 | -12 | -14 | -20 | -11 | -2 | |
Depreciation | -13 | -14 | -19 | -21 | -24 | -29 | -37 | -41 | -48 | -55 | |
Taxation | -10 | -19 | -23 | -18 | -20 | -26 | -35 | -30 | -44 | -45 | |
Exceptional Items | 10 | 20 | |||||||||
PAT | 23 | 44 | 62 | 47 | 55 | 69 | 64 | 94 | 133 | 134 | |
Minority Interest | 0 | ||||||||||
Share Associate | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | |
Other Related Items | |||||||||||
Consolidated Net Profit | 24 | 45 | 62 | 48 | 55 | 71 | 65 | 96 | 136 | 136 | |
Adjusted EPS | 3 | 5 | 7 | 5 | 6 | 8 | 7 | 11 | 14 | 14 |
Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
Cash Fr. Operatn. | 33 | 39 | 66 | 63 | 63 | 56 | 75 | 106 | 128 | 119 | |
Cash Fr. Inv. | -26 | -31 | -58 | -59 | -31 | -56 | -88 | -101 | -107 | -436 | |
Cash Fr. Finan. | -6 | -8 | 5 | -6 | -31 | 0 | 16 | -5 | -21 | 317 | |
Net Change | 0 | 0 | 13 | -2 | 1 | 0 | 3 | 1 | 1 | 0 | |
Cash & Cash Eqvt | 1 | 1 | 14 | 12 | 13 | 1 | 4 | 4 | 5 | 5 |
Thu, 04 Aug 2022
Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations 2015 <BR> Dear Sir/Madam Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations 2015 We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th August 2022 at 232-B 3RD Floor Okhla Industrial Estate Phase-III New Delhi - 110020 approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2022. b) Allotted 18 050 Equity Shares of Rs. 5 each pursuant to exercise of an option under Employee Stock Option Scheme 2016. c) Ratification of Remuneration to M/ s. Jai Prakash & Company Cost Accountants appointed as Cost Auditors of the Company for the Financial Year 2022-23 subject to the approval of the shareholders in the forthcoming Annual General Meeting. d) Resolution for Shareholders approval for re-appointment and remuneration of Mr. Vishal Baid as Sr. President (Sales and Marketing) of the Company in the forthcoming Annual General Meeting. |
Thu, 04 Aug 2022
Financial Results(Standalone & Consolidated) For The Quarter Ended 30Th June 2022 In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations 2015 Dear Sir/Madam Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations 2015 We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th August 2022 at 232-B 3RD Floor Okhla Industrial Estate Phase-III New Delhi - 110020 approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2022. |
Tue, 02 Aug 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Dear Sir/Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that an earnings call will be held on Friday 5th August 2022 at 3.00 p.m. (IST) for discussing the Un-Audited Financial Results of the Company for the quarter ended 30th June 2022.Link for joining Dial in and other details of the call are enclosed herewith.ICICI Securities Limited through its representatives along with Companys officials will coordinate the aforesaid meeting.This is for your information and record.Thanking You |
Thu, 18 Aug 2022 |
|
|
|
|
|